Biomarkers for Predicting Cognitive Decline in Parkinson’s Disease May Improve Future Clinical Trials
A range of biomarkers may help physicians predict which Parkinson’s disease patients will develop cognitive decline in the early years of a diagnosis, say researchers at the University of Pennsylvania. The information may help manage the disease better, but will be especially valuable in future clinical trials. For the…